Phillips K A
Center for AIDS Prevention Studies, School of Medicine, University of California-San Francisco 94105.
J Acquir Immune Defic Syndr (1988). 1994 Apr;7(4):403-9.
This study analyzed whether state HIV testing policies were related to individuals' previous and planned voluntary use of HIV testing. Testing plays an important role in the prevention and treatment of HIV infection, yet little is known about how policies are related to testing use. Most states mandate the conditions under which testing is performed, but states vary widely in their policies. This cross-sectional study analyzed individual-level data from the 1988 AIDS Knowledge and Attitudes Survey, which was merged with state-level data on testing policies and incidence of AIDS cases. A multivariate regression model was used to assess the relationship of state policies to testing use, holding state AIDS incidence and individual characteristics (sociodemographics, AIDS knowledge, and risk status) constant. Individuals in states with policies protective of individual rights (i.e., early adoption of comprehensive antidiscrimination laws restricting screening by insurers and employers; provision of voluntary, anonymous testing) were significantly more likely to have been tested than individuals in comparison states (odds ratio = 1.5). Individual characteristics such as risk status, however, had the strongest relationships to testing use. No evidence was found that name-reporting requirements were related to previous or planned use of testing. Future research must address emerging testing issues such as policies covering the use of new testing technologies.
本研究分析了各州的艾滋病病毒检测政策是否与个人之前及计划进行的自愿艾滋病病毒检测有关。检测在艾滋病病毒感染的预防和治疗中起着重要作用,但对于政策与检测使用之间的关系却知之甚少。大多数州规定了进行检测的条件,但各州的政策差异很大。这项横断面研究分析了1988年艾滋病知识与态度调查中的个人层面数据,该数据与各州的检测政策及艾滋病病例发病率数据相结合。使用多元回归模型来评估州政策与检测使用之间的关系,同时保持州艾滋病发病率和个人特征(社会人口统计学、艾滋病知识及风险状况)不变。与对照州的个人相比,所在州制定了保护个人权利政策(即较早通过限制保险公司和雇主进行筛查的全面反歧视法律;提供自愿、匿名检测)的个人进行检测的可能性显著更高(优势比=1.5)。然而,风险状况等个人特征与检测使用的关系最为密切。未发现有证据表明实名报告要求与之前或计划进行的检测使用有关。未来的研究必须解决新出现的检测问题,如涉及新检测技术使用的政策。